ORCHID PHARMA
Quarterly Results Analysis [Dec2023]
ORCHID PHARMA Quarterly Results
Consolidated | Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹221 Cr | ₹199 Cr | ₹183 Cr | ₹210 Cr | ₹160 Cr | ₹165 Cr | ₹131 Cr | ₹178 Cr |
Expenses | ₹185 Cr | ₹175 Cr | ₹161 Cr | ₹170 Cr | ₹146 Cr | ₹147 Cr | ₹119 Cr | ₹152 Cr |
Operating Income | ₹35 Cr | ₹23 Cr | ₹22 Cr | ₹40 Cr | ₹14 Cr | ₹18 Cr | ₹12 Cr | ₹26 Cr |
Other Income | ₹8 Cr | ₹8 Cr | ₹2 Cr | ₹2 Cr | ₹9 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹8 Cr | ₹4 Cr |
Depreciation | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹18 Cr | ₹22 Cr | ₹27 Cr |
Profit Before Tax | ₹30 Cr | ₹20 Cr | ₹11 Cr | ₹66 Cr | ₹7 Cr | ₹-3 Cr | ₹-14 Cr | ₹-4 Cr |
Profit After Tax | ₹30 Cr | ₹20 Cr | ₹11 Cr | ₹66 Cr | ₹7 Cr | ₹-3 Cr | ₹-14 Cr | ₹-4 Cr |
EPS | ₹5.80 | ₹3.90 | ₹1.85 | ₹14.49 | ₹1.86 | ₹-1.32 | ₹-3.68 | ₹-1.61 |
Industry Peers & Returns | 1W | 1M | 1Y |
ORCHID PHARMA | -3.9% | -6% | 172.7% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -7.5% | 53.9% |
CIPLA | 1.1% | -4.8% | 56.4% |
DR REDDYS LABORATORIES | 1.6% | 1.6% | 27.6% |
ZYDUS LIFESCIENCES | 5.2% | -0.2% | 90.1% |
DIVIS LABORATORIES | -1.9% | 10.7% | 21.4% |
MANKIND PHARMA | -2.3% | 0.1% | NA |
TORRENT PHARMACEUTICALS | 1.6% | 2% | 61.8% |
LUPIN | 2.4% | 2% | 132.5% |
ORCHID PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 10.99 % |
Y-o-Y | 38.08 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹221 Cr | 10.99 | |
Sep2023 | ₹199 Cr | 8.66 | |
Jun2023 | ₹183 Cr | -12.85 | |
Mar2023 | ₹210 Cr | 31.39 | |
Dec2022 | ₹160 Cr | -3.32 | |
Sep2022 | ₹165 Cr | 26.16 | |
Jun2022 | ₹131 Cr | -26.47 | |
Mar2022 | ₹178 Cr | - |
ORCHID PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 51.79 % |
Y-o-Y | 159.11 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹35 Cr | 51.79 | |
Sep2023 | ₹23 Cr | 5.29 | |
Jun2023 | ₹22 Cr | -44.21 | |
Mar2023 | ₹40 Cr | 190.58 | |
Dec2022 | ₹14 Cr | -23.37 | |
Sep2022 | ₹18 Cr | 43.16 | |
Jun2022 | ₹12 Cr | -51.68 | |
Mar2022 | ₹26 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 36.74 % |
Y-o-Y | 87.60 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 16.04% | 36.74 | |
Sep2023 | 11.73% | -3.14 | |
Jun2023 | 12.11% | -35.96 | |
Mar2023 | 18.91% | 121.17 | |
Dec2022 | 8.55% | -20.76 | |
Sep2022 | 10.79% | 13.58 | |
Jun2022 | 9.5% | -34.30 | |
Mar2022 | 14.46% | - |
ORCHID PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 50.78 % |
Y-o-Y | 348.75 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹30 Cr | 50.78 | |
Sep2023 | ₹20 Cr | 85.84 | |
Jun2023 | ₹11 Cr | -83.66 | |
Mar2023 | ₹66 Cr | 879.95 | |
Dec2022 | ₹7 Cr | Positive | |
Sep2022 | ₹-3 Cr | Negative | |
Jun2022 | ₹-14 Cr | Negative | |
Mar2022 | ₹-4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 35.95 % |
Y-o-Y | 225.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 13.69 % | 35.95 | |
Sep2023 | 10.07 % | 70.97 | |
Jun2023 | 5.89 % | -81.25 | |
Mar2023 | 31.41 % | 646.08 | |
Dec2022 | 4.21 % | Positive | |
Sep2022 | -2.01 % | Negative | |
Jun2022 | -10.76 % | Negative | |
Mar2022 | -2 % | - |
ORCHID PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 48.72 % |
Y-o-Y | 211.83 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹5.8 | 48.72 | |
Sep2023 | ₹3.9 | 110.81 | |
Jun2023 | ₹1.85 | -87.23 | |
Mar2023 | ₹14.49 | 679.03 | |
Dec2022 | ₹1.86 | Positive | |
Sep2022 | ₹-1.32 | Negative | |
Jun2022 | ₹-3.68 | Negative | |
Mar2022 | ₹-1.61 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD